1BAYAT A,BOCK O,MROWIETZ U,et al.Genetic susceptibility to keloid disease:transforming growth factor beta receptor gene polymorphisms are not associated with keloid disease[J].Exp Dermatol,2004,13(2):120-124.
2BAYAT A,BOCK O,MROWIETZ U,et al.Genetic susceptibility to keloid disease and hypertrophic scarring:transforming growth factor beta1 common polymorphisms and plasma levels[J].Reconstr Surg,2003,11(2):535,discussion 544-546.
3MARNEROS A G,NORRIS J E,WATANABE S,et al.Genome scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7p11[J].J Invest Dermatol,2004,122(5):1126-1132.
4PHAN T T,LIM I J,BAY B H,et al.Role of IGF system of mitogens in the induction of fibroblast proliferation by keloid-derived keratinocytes in vitro[J].Am J Physiol Cell Physiol,2003,284(4):C860-C869.
5DAIAN T,OHTSURU A,ROGOUNOVITCH T,et al.Insulin-like growth factor-I enhances transforming growth factor-beta-induced extracellular matrix protein production through the P38/activating transcription factor-2 signaling pathway in keloid fibroblasts[J].J Invest Dermatol,2003,120(6):956-962.
7GIRA A K,BROWN L F,WASHINGTON C V,et al.Keloids demonstrate high-level epidermal expression of vascular endothelial growth factor[J].J Am Acad Dermatol,2004,50(6):850-853.
8WU Y,ZHANG Q,ANN D K,et al.Increased vascular endothelial growth factor may account for elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid fibroblasts[J].Am J Physiol Cell Physiol,2004,286(4):C905-C912.
9XIA W,PHAN T T,LIM I J,et al.Complex epithelial-mesenchymal interactions modulate transforming growth factor-beta expression in keloid-derived cells[J].Wound Repair Regen,2004,12(5):546-556.
10FUNAYAMA E,CHODON T,OYAMA A,et al.Keratinocytes promote proliferation and inhibit apoptosis of the underlying fibroblasts:an important role in the pathogenesis of keloid[J].J Invest Dermatol,2003,121(6):1326-1331.
二级参考文献33
1Kamb A, Gruis NA, Weaver J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science, 1994, 264 :436 - 440.
2Noborl T, Miura K, Wu DJ, et al. Deletions of the cyclin-depend-ent kinase-4 inhibitor gene in multiple human cancers. Nature,1994,368 : 753 - 756.
3Rocco JW, Sidransky D. p16(MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res, 2001,264:42 - 55.
4Brissett AE, Sherris DA, Scar contractures, hypertrophic scars, and keloids. Facial Plast Surg, 2001,17:263 - 272.
5Shaffer JJ, Taylor SC, Cook F. Keloidal scars: a review with a critical look at therapeutic options. J Am Acad Dermatol, 2002 ,46Supp1:63 - 97.
6Giovannini UM. Treatment of scars by steroid injections, Wound Repair Regen, 2002,10 : 116 - 117.
7Desmouliere A, Redard M, Darbu L. Apoptosis mediate the decrease in cellularity during the transition between granulation tissue and scar [J]. Am J Pathol, 1995, 32(2): 146-56.
8Garbin S, Pittet B, Montandon D, et ol. Covering by a flap induces apoptosis of granulation tissue fibroblasts and vascular cells [J].Wound Repair Regener, 1996, 24(4): 244-6.
9Su Y, Arnold f, Cherry G, et o2. Proliferation and apoptosis in chronic wounds[J]. Wound Repair Regener, 1996, 24(6): 141-6.
10Naoto I, Shin Y, Ai I, et oi. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis [J]. Cell,1991, 66(3): 233-43.
